Home INDUSTRY news Agenus and Zydus Lifesciences Enter $141MM Partnership that Includes Transfer of Facilities in Emeryville and Berkeley
INDUSTRY newsLife ScienceNews Releases

Agenus and Zydus Lifesciences Enter $141MM Partnership that Includes Transfer of Facilities in Emeryville and Berkeley

Share
viles filled with medicine
Photo by Louis Reed on Unsplash
Share

(Editor's Note: According to industry reports, the Berkeley facility is 25,000 square feet and located at 901 Heinz Ave., and the Emeryville asset spans 83,000 square feet and is positioned at  6455 Christie Ave.) LEXINGTON, Mass.-- Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifesciences […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

Prado Group Takes Over 721 Veritas Apartments in San Francisco, Lands $265.7MM Loan

The 23-building, mostly rent-controlled portfolio is the second Prado has taken from...

Brookfield’s $26B Fund VI Haul Sets Up a New Wave of Capital for Northern California Power and AI Assets

Brookfield Asset Management has lined up $26 billion for its sixth flagship...

Hudson Pacific Claims Full Coverage on Rincon Center’s 163,000 SQFT Salesforce-Twilio Roll in San Francisco

Hudson Pacific Properties told investors on its third-quarter call that it is...